# Study of PI-88 in Patients With Advanced Melanoma

> **NCT00068172** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cellxpert Biotechnology Corp.** · enrollment: 88 (—)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** PI-88

## Key facts

- **NCT ID:** NCT00068172
- **Lead sponsor:** Cellxpert Biotechnology Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 88 (—)
- **Last updated:** 2022-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068172, "Study of PI-88 in Patients With Advanced Melanoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00068172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*